Study Confirms Clinical Benefit for Interleukin-2

Patients with metastatic renal cell carcinoma face a poor prognosis; currently, 30% of patients already have metastatic disease at the time of diagnosis, according to national data.05/07/2014
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news